KURA – kura oncology, inc. (US:NASDAQ)
Stock Stats
News
Kura Oncology to Report First Quarter 2024 Financial Results
Kura Oncology, Inc. (NASDAQ: KURA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $32.00 price target on the stock.
Kura Oncology Receives Breakthrough Therapy Designation for Ziftomenib in NPM1-Mutant AML [Yahoo! Finance]
Kura Oncology Receives Breakthrough Therapy Designation for Ziftomenib in NPM1-Mutant AML
Kura Oncology, Inc. (NASDAQ: KURA) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Form ARS Kura Oncology, Inc. For: Dec 31
Form DEF 14A Kura Oncology, Inc. For: Apr 12
Form DEFA14A Kura Oncology, Inc.
Form S-8 Kura Oncology, Inc.
Form 10-K Kura Oncology, Inc. For: Dec 31
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.